Evidence map›Paper›PMID 38517025›Full record

ArticleAmerican journal of epidemiology2024

Targeted learning with an undersmoothed LASSO propensity score model for large-scale covariate adjustment in health-care database studies.

Richard Wyss, Mark van der Laan, Susan Gruber, Xu Shi, Hana Lee, Sarah K Dutcher, Jennifer C Nelson, Sengwee Toh, Massimiliano Russo, Shirley V Wang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Richard WyssDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Mark van der LaanDivision of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA 94720, United States.
Susan GruberPutnam Data Sciences, LLC, Cambridge, MA 02139, United States.
Xu ShiDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, United States.
Hana LeeOffice of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20903, United States.
Sarah K DutcherOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20903, United States.
Jennifer C NelsonKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, United States.
Sengwee TohDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States.
Massimiliano RussoDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Shirley V WangDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Kueiyu Joshua LinDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Brigham and Women's Hospital · USCenter for Drug Evaluation and Research · USData Sciences International (United States) · USHarvard Pilgrim Health Care · USHarvard University · USKaiser Permanente Washington Health Research Institute · USUniversity of California, Berkeley · USUniversity of Michigan–Ann Arbor · US

Funding

Developing scalable algorithms to incorporate unstructured electronic health records for causal inference based on real-world dataR01LM013204 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI LIN, JOSHUA K · 2020 to 2024
$2.7M
NIH HHS RO1LM013204NLM NIH HHS R01 LM013204Patient-Centered Outcomes Research Institute ME-2022C1-25646US Food and Drug Administration 75F40119D10037
6 · The paper itself

Abstract

Least absolute shrinkage and selection operator (LASSO) regression is widely used for large-scale propensity score (PS) estimation in health-care database studies. In these settings, previous work has shown that undersmoothing (overfitting) LASSO PS models can improve confounding control, but it can also cause problems of nonoverlap in covariate distributions. It remains unclear how to select the degree of undersmoothing when fitting large-scale LASSO PS models to improve confounding control while avoiding issues that can result from reduced covariate overlap. Here, we used simulations to evaluate the performance of using collaborative-controlled targeted learning to data-adaptively select the degree of undersmoothing when fitting large-scale PS models within both singly and doubly robust frameworks to reduce bias in causal estimators. Simulations showed that collaborative learning can data-adaptively select the degree of undersmoothing to reduce bias in estimated treatment effects. Results further showed that when fitting undersmoothed LASSO PS models, the use of cross-fitting was important for avoiding nonoverlap in covariate distributions and reducing bias in causal estimates.

Indexed as

Propensity ScoreBiasComputer SimulationConfounding Factors, EpidemiologicDatabases, FactualHumansModels, Statisticalcausal inferenceconfoundingLASSOpropensity scoretargeted learning

Identifiers

PMID38517025
PMCPMC11538566
OpenAlexW4393096466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.